天津金耀药业有限公司

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — abuse of a dominant market position (津市监垄处〔2023〕1号 · 市场监管总局发布天津金耀药业有限公司滥用市场支配地位案行政处罚决定书), from 22 March 2023.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Abuse of a dominant market position.

Details

Company

天津金耀药业有限公司

Authority

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)

Decision

Abuse of a dominant market position

Grounds and details, as published

津市监垄处〔2023〕1号 · 市场监管总局发布天津金耀药业有限公司滥用市场支配地位案行政处罚决定书

From

22 March 2023

Until

—

Status

End date not published

Source

https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_f38e7ff72e644e1f8d43459b35aeac10.html

Licence

Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)